Portfolio map · Investment firm · United States
National Cancer Institute (NCI) portfolio map
47 startups National Cancer Institute (NCI) has backed in rounds we track, since 2014, grouped by their main sector. Together they have raised $494M. The biggest sector is Biotech, with 35 companies.
Biotech
35- IIgenica
- CTChrono Therapeutics
Advanced Cell Diagnostics
Tiga TX
Linnaeus Therapeutics
Transcode Therapeutics
Previse
AiM Medical Robotics
Vivere Oncotherapies
Agilvax- MBModifi Bio
Microvascular Therapeutics
Immunicom
Helocyte
Resolute Science
Lamassu Pharma
Trethera
Intus Bio
Xylyx Bio
KinaRx
Voximetry
Saros Therapeutics
Flexomics
Isabl Inc.
+11 more
Funding by segment
- Biotech$402M35
- Healthtech$76M8
- AI$16M4
Where they are based
- United States43$459M
- United Kingdom1$23M
United States
United KingdomFounded
2 without a founding year on record.
Total raised
- Under $1M12
- $1M to $10M23
- $10M to $50M10
- $50M to $250M2
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
44 of 47 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States43
- United Kingdom1
Startups by country, 2 countries in all.
Segment by segment
Biotech
35 startups · $402M raised
- IIgenicaIgenica engages in discovery and development of antibody-based therapeutics for the treatment of cancer.United States$88M
- CTChrono TherapeuticsChrono Therapeutics was founded by Guy DiPierro to cause a paradigm shift in the way addictions and diseases are treated.United States$83M
- Advanced Cell DiagnosticsAdvanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.United States$41M
- Tiga TXTiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.United States$36M
- Linnaeus TherapeuticsLinnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.United States$32M
- Transcode TherapeuticsTransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.United States$26M
- PrevisePrevise is a London-based financial services and technology company that focuses on improving payment processes for businesses.United Kingdom$23M
- AiM Medical RoboticsAiM Medical Robotics is a privately held company based in Worcester, Massachusetts, focused on developing a portable, MRI-compatibUnited States$16M
Healthtech
8 startups · $76M raised
QT ImagingQT Imaging is a scanning center that provides breast imaging by tomographic transmission ultrasound for patients.United States$28M
ZetaGen TherapeuticsZetagen Therapeutics is a private, clinical-stage biopharmaceutical company based in Syracuse, New York, founded in 2015.United States$26M- AAAdvocate Aurora HealthAdvocate Aurora Health is a Healthcare-$10M
- ACAdvanced Chemotherapy TechnologiesAdvanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.United States$4.0M
OnLumeOnLume is a medical device company based in Madison, Wisconsin, specializing in fluorescence image-guided surgery technology.United States$2.8M
Ananya HealthAnanya Health is a seed-stage medical device company focused on improving cervical cancer prevention.United States$2.7M
MALCOVAMALCOVA is a medical device startup delivering novel hardware and AI-based software solutions to resolve needs in the radiology market.United States$2.2M
Symple SurgicalSymple Surgical is a medical device company focusing on developing novel therapeutic technologies through controlled microwave ablation.United States$400K
AI
4 startups · $16M raised
Quiver BioscienceQuiver Bioscience develops medicines for brain disorders using human disease models and AI to advance drug development.United States$9.3M
Sinopia BiosciencesSinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.United States$3.6M
HistolixHistolix provides an intrinsically digital and slide-free histopathology solution.United States$3.2M
Voxel HealthcareClinical Decision Support for Pediatric Radiology-$225K
How this map is made. Every startup here has raised money in a round we track that names National Cancer Institute (NCI) as an investor, the first in 2014. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like National Cancer Institute (NCI)?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.